Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Mar 18 2025
Dec 4 2025
Jan 27 2026
Apr 21 2025
Oct 10 2025